Impact of Medical Fee Revisions and Lower Medical Material Prices

「Although the FY2026 medical fee revision included enhanced evaluations for addressing rising prices and wages, improving the treatment of healthcare professionals, promoting medical DX and maintaining regional healthcare delivery systems, various expenses, including personnel and utility costs, as well as medical material prices, continue to rise, and profitability has still not improved sufficiently.」

「Meanwhile, the FY2024 medical fee revision rates were decided and announced, with the medical service component increasing by 0.88% and drug and material prices decreasing by a combined 1.0%.」

「Meanwhile, the basic policy for the fiscal 2024 medical fee revision has been presented, addressing economic and social conditions such as higher prices and wages and the need to secure medical and long-term care personnel.」

「Meanwhile, as medical operating expenses trend higher due to a sharp rise in prices and energy costs and the need to secure funding for wage increases, discussions have begun on formulating the basic policy for the FY2024 medical fee revision.」

「Demands from individual companies for lower delivered prices remain severe,」

「In the healthcare industry in which our Group operates, medical fees were revised in April 2022, and the development of the healthcare delivery system as part of the social security framework continues to be pursued.」

「In the healthcare industry in which our Group operates, medical fees were revised in April 2022, and the transformation of the healthcare delivery system as part of the social security framework continues to be pursued.」

「In the healthcare industry in which our Group operates, medical fees were revised in April this year, and the transformation of the healthcare delivery system as part of the social security framework continues to be pursued.」

「In the medical device industry, although demand associated with the integration and consolidation of medical institutions to realize regional healthcare plans is expanding, prices for medical materials continue to decline, including a 0.02% reduction under the medical fee revision implemented in April this year.」

「Medical material prices were reduced by 0.02% under the latest medical fee revision, among other factors, and prices for medical materials continue to decline.」

「In the medical device industry, although demand is expanding, unit prices for medical materials continue to decline, including a 0.02% reduction in medical material prices under the latest medical fee revision.」

「In the medical device industry, although demand is expanding, unit prices for medical materials continue to decline under the government's policies to contain healthcare spending.」

「The medical equipment industry is seeing greater demand for proposals that help medical institutions improve their management. Companies are therefore required to further strengthen price competitiveness, improve profitability through cost reductions, and enhance their ability to respond to customer needs.」

「In the medical device industry, in addition to demands for lower selling prices following revisions to reimbursement prices, requests for proposals that help medical institutions improve their management are increasing. Companies are therefore required to further strengthen their price competitiveness, improve profitability through cost reductions and enhance their ability to respond to customer needs.」

「It has also been decided that the revision of medical and long-term care fees accompanying the consumption tax increase in October this year will result in a 0.41% increase in medical fees, a 0.51% decrease in drug prices and a 0.03% increase in material prices.」

「In the medical device industry in which our Group operates, partly due to the impact of lower selling prices for medical materials following the April 2018 medical fee revision,」

「Due to the impact of lower selling prices for medical materials following the medical fee revision implemented in April this year,」

「Under this revision, four pillars were established to indicate the future direction of healthcare toward 2025, when the baby-boomer generation will be aged 75 or older: establishing a community-based integrated care system, realizing and enhancing high-quality healthcare, reforming the working practices of healthcare professionals, and improving the stability and sustainability of the system. The medical service component was increased by 0.55%, while, continuing the approach taken in the previous revision, drug prices were reduced by 1.65% and medical material prices by 0.09%.」

「Under the fiscal 2018 revision of medical service fees, the revision rate for the basic medical fee component was set at an increase of 0.63%, while the overall revision was a 1.19% decrease and medical materials were reduced by 0.09%.」